日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xenopus laevis Gamma-aminobutyric acid receptor-associated protein-like 1 (gabarapl1) CSB-YP743449XBE
CSB-EP743449XBE
CSB-BP743449XBE
CSB-MP743449XBE
CSB-EP743449XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis LSM domain-containing protein 1-A (lsmd1-a) CSB-YP743450XBE
CSB-EP743450XBE
CSB-BP743450XBE
CSB-MP743450XBE
CSB-EP743450XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Mediator of RNA polymerase II transcription subunit 31-B (med31-b) CSB-YP743451XBE
CSB-EP743451XBE
CSB-BP743451XBE
CSB-MP743451XBE
CSB-EP743451XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis AT-rich interactive domain-containing protein 3A (arid3a), partial CSB-YP743452XBE
CSB-EP743452XBE
CSB-BP743452XBE
CSB-MP743452XBE
CSB-EP743452XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Probable arginine--tRNA ligase, mitochondrial (rars2), partial CSB-YP743453XBE
CSB-EP743453XBE
CSB-BP743453XBE
CSB-MP743453XBE
CSB-EP743453XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Trans-2-enoyl-CoA reductase, mitochondrial (mecr) CSB-YP743454DIL
CSB-EP743454DIL
CSB-BP743454DIL
CSB-MP743454DIL
CSB-EP743454DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Uncharacterized protein C16orf59 homolog CSB-YP743455MO
CSB-EP743455MO
CSB-BP743455MO
CSB-MP743455MO
CSB-EP743455MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Embryonic polyadenylate-binding protein B (epabp-b), partial CSB-YP743456XBE
CSB-EP743456XBE
CSB-BP743456XBE
CSB-MP743456XBE
CSB-EP743456XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Syndecan-2-B (sdc2-b), partial CSB-YP743457XBE
CSB-EP743457XBE
CSB-BP743457XBE
CSB-MP743457XBE
CSB-EP743457XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes 40S ribosomal protein S4, Y isoform 2 (RPS4Y2) CSB-YP743458EQV
CSB-EP743458EQV
CSB-BP743458EQV
CSB-MP743458EQV
CSB-EP743458EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Uncharacterized protein 098R (FV3-098R) CSB-YP743459FDG
CSB-EP743459FDG
CSB-BP743459FDG
CSB-MP743459FDG
CSB-EP743459FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Putative FAD-linked sulfhydryl oxidase 088R (FV3-088R) CSB-YP743460FDG
CSB-EP743460FDG
CSB-BP743460FDG
CSB-MP743460FDG
CSB-EP743460FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Putative transcription elongation factor S-II-like protein 81R (FV3-081R) CSB-YP743461FDG
CSB-EP743461FDG
CSB-BP743461FDG
CSB-MP743461FDG
CSB-EP743461FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Uncharacterized protein 070R (FV3-070R) CSB-YP743462FDG
CSB-EP743462FDG
CSB-BP743462FDG
CSB-MP743462FDG
CSB-EP743462FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Putative ribonucleoside-diphosphate reductase small subunit 067L (FV3-067L) CSB-YP743463FDG
CSB-EP743463FDG
CSB-BP743463FDG
CSB-MP743463FDG
CSB-EP743463FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Putative phosphotransferase 057R (FV3-057R) CSB-YP743464FDG
CSB-EP743464FDG
CSB-BP743464FDG
CSB-MP743464FDG
CSB-EP743464FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Putative myristoylated protein 053R (FV3-053R), partial CSB-YP743465FDG1
CSB-EP743465FDG1
CSB-BP743465FDG1
CSB-MP743465FDG1
CSB-EP743465FDG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Uncharacterized protein 046L (FV3-046L) CSB-YP743466FDG
CSB-EP743466FDG
CSB-BP743466FDG
CSB-MP743466FDG
CSB-EP743466FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Uncharacterized protein 035L (FV3-035L) CSB-YP743467FDG
CSB-EP743467FDG
CSB-BP743467FDG
CSB-MP743467FDG
CSB-EP743467FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frog virus 3 Uncharacterized protein 027R (FV3-027R), partial CSB-YP743468FDG
CSB-EP743468FDG
CSB-BP743468FDG
CSB-MP743468FDG
CSB-EP743468FDG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×